Herpes-simplex-Keratitis. Ein kurzer Überblick zur aktuellen Therapie

 

 Buy Article Permissions and Reprints

Zusammenfassung

In dieser Übersicht werden aktuelle Therapieempfehlungen zur Herpes-simplex-Keratitis gegeben. Dabei sind nach einer Literaturrecherche Daten von 2000 bis einschließlich 2009 zusätzlich zu früheren zusammengefasst. Im Wesentlichen werden die medikamentöse Behandlung der oberflächlichen, epithelialen Keratitis, der tiefen, stromalen Keratitis, der Rezidivprophylaxe und der metaherpetischen Keratitis behandelt. Schließlich wird ein Therapieschema präsentiert.

Abstract

In this review the current recommendations for the treatment of Herpes simplex keratitis are given – based on the literature, especially from 2000 till 2009. The medical treatment of epithelial, deep stromal keratitis, the prevention of recurrences and metaherpetic keratitis are discussed. Finally, a therapy scheme is presented.

Literatur

• 1 Wander A H, Centifanto Y M, Kaufman H E. Strain specificity of clinical isolates of herpes simplex virus.  Arch Ophthalmol. 1980;  98 1458-1461
  Google Scholar
• 2 Kaufman H E, Centifanto-Fitzgerald Y M, Varnell E D. Herpes simplex keratitis.  Ophthalmology. 1983;  90 700-706
  Google Scholar
• 3 Kaufman H E. Update on antiviral agents.  Ophthalmology. 1985;  92 533-536
  Google Scholar
• 4 Kaufman H E. A new understanding of ocular herpetic disease.  Am J Ophthalmol. 1982;  33 119-121
  Google Scholar
• 5 Remeijer L, Maertzdorf J, Doornenbal P et al. Herpes simplex virus 1 transmission through corneal transplantation.  Lancet. 2001;  357 442
  Google Scholar
• 6 Remeijer L, Maertzdorf J, Buitenwerf J et al. Corneal herpes simplex virus type1 superinfection in patients mit recrudescent herpetic keratitis.  Invest Ophthalmol Vis Sci. 2002;  43  358-363
  Google Scholar
• 7 Sundmacher R. Color atlas of herpetic eye disease. A practical guide to clinical management. Berlin Heidelberg: Springer-Verlag; 2009
  Google Scholar
• 8 Wilhelmus K R. .Therapeutic interventions for herpes simplex virus epithelial keratitis [Review]. The Cochrane Collaboration. John Wiley and Sons, Ltd; 2009
  Google Scholar
• 9 Stránská R, Schuurman R, Nienhuis E et al. Survey of aciclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.  J Clin Virol. 2005;  32  7-18
  Google Scholar
• 10 Iwayama S, Ono N, Ohmura Y et al. Antiherpesvirus activities of (1’S,2’R)-9-{[1’,2’-bis(hydroxymethyl)cycloprop-1’yl]methyl}guanine (A-5021) in cell culture.  Antimicrob Agents Chemother. 1998;  42 1666-1670
  Google Scholar
• 11 Iwayama S, Ohmura Y, Suzuki K et al. Evaluation of anti-herpesvirus activity of (1’S,2’R)-9-{[1’,2’-bis(hydroxymethyl)cycloprop-1’yl]methyl}guanine (A-5021) in mice.  Antiviral Res. 1999;  42 139-148
  Google Scholar
• 12 Itahashi M, Higaki S, Sugahara D et al. A-5021. A new Acyclovir analogue inhibits murine herpetic keratitis.  Cornea. 2008;  27 334-338
  Google Scholar
• 13 Sozen E, Avunduk A M, Akyol N. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial.  Chemotherapy. 2006;  52 29-31
  Google Scholar
• 14 Higaki S, Itahashi M, Deai T et al. Effect of oral valaciclovir on herpetic keratitis.  Cornea. 2006;  25 S64-S67
  Google Scholar
• 15 Duan R, Vries R D, Osterhaus A DME et al. Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.  J Infect Dis. 2008;  198  659-663
  Google Scholar
• 16 Bacon T H, Levin M J, Leary J J et al. Herpes simplex virus resistance to Acyclovir and Penciclovir after two decades of antiviral therapy.  Clin Microbiol Rev. 2003;  16 114-128
  Google Scholar
• 17 Danve-Szatanek de C, Aymard M, Thouvenot D et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.  J Clin Microbiol. 2004;  42 242-249
  Google Scholar
• 18 Power W J, Benedict-Smith A, Hillery M et al. Randomised double-blind trial of bromovinyldeoxyuridine (BVDU) and trifluorothymidine (TFT) in dendritic corneal ulceration.  Br J Ophthalmol. 1991;  75 649-651
  Google Scholar
• 19 Behrens-Baumann W. Phosphonoformate (Foscarnet, PFA) versus Trifluorthymidine in the treatment of keratitis dendritica in the human. A double-blind, randomized, preliminary trial.  Acta Ophthalmol. 1992;  70 690-692
  Google Scholar
• 20 Helgstrand E, Eriksson B, Johansson N G et al. Trisodium phosphonoformate, a new antiviral compound.  Science. 1978;  201 819-821
  Google Scholar
• 21 Levin M J, Weinberg A, Leary J J et al. Development of Acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.  Pediatric Infect Dis J. 2001;  20 1094-1097
  Google Scholar
• 22 Colin J. Ganciclovir ophthalmic gel, 0.15 %: a valuable tool for treating ocular herpes.  Clin Ophthalmol. 2007;  4 441-453
  Google Scholar
• 23 Hoh H B, Hurley C, Claoue C et al. Randomised trial of gancoglivir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.  Br J Ophthalmol. 1996;  80 140-143
  Google Scholar
• 24 Kaufman H E. Ganciclovir: a promising topical antiviral gel for herpetic keratitis.  Expert Rev Ophthalmol. 2009;  4 367-375
  Google Scholar
• 25 Zhang J, Gao C, Wang L. Ocular pharmacokinetics and bioavailability of 0.2 % ganciclovir in-situ gelling eye drops.  Chin J Ophthalmol. 2006;  42 637-641
  Google Scholar
• 26 Sundmacher R. Herpestherapie und -prophylaxe.  Klin Monatsbl Augenheilkd. 1976;  169 308-325
  Google Scholar
• 27 Behrens-Baumann, W, Weber, U, Ansorg, R Trifluorthymidin und bakterielle Hornhautinfektion. Eine tierexperimentelle Studie. München; 1981: 291-294
  Google Scholar
• 28 Behrens-Baumann W, Weber U, Ansorg R. Azyklovir und bakterielle Hornhautinfektion. Eine tierexperimentelle Studie.  Ber Dtsch Ophthalmol Ges. 1981;  78 399-401
  Google Scholar
• 29 Yamaguchi K, Okumoto M, Stern G et al. Idoxuridine and bacterial corneal infection.  Am J Ophthalmol. 1979;  87 202-205
  Google Scholar
• 30 Barron B A, Gee L, Hauck W W et al. Herpetic eye disease study.  Ophthalmology. 1994;  101 1871-1882
  Google Scholar
• 31 Knickelbein J E, Hendricks R L, Charukamnoetkanok P. Management of herpes simplex virus stromal keratitis: an evidence-based review.  Surv Ophthalmol. 2009;  54 226-234
  Google Scholar
• 32 Inoue Y. Immunological aspects of herpetic stromal keratitis.  Sem Ophthalmol. 2008;  23 221-227
  Google Scholar
• 33 Wilhelmus K R. Diagnosis and management of herpes simplex stromal keratitis.  Cornea. 1987;  6 286-291
  Google Scholar
• 34 Collum L MT, Logan P, Ravenscroft T. Acyclovir (Zovirax) in herpetic disciform keratitis.  Br J Ophthalmol. 1983;  67 115-118
  Google Scholar
• 35 Wilhelmus K R, Gee L, Hauck W W et al. Herpetic eye disease study.  Ophthalmology. 1994;  101 1883-1896
  Google Scholar
• 36 Behrens-Baumann W, Quentin C D, Vogel M. Acyclovir versus Trifluorthymidin in der Therapie der stromalen Herpes-Keratitis.  Klin Monatsbl Augenheilkd. 1986;  189 286-288
  Google Scholar
• 37 Pleyer U, Mondino B J, Adamus S A et al. Immune response to Staphylococcus epidermidis endophthalmitis in a rabbit model.  Invest Ophthalmol Vis Sci. 1992;  33  2650-2663
  Google Scholar
• 38 Kain H L. Prinzipien in der Behandlung der Endophthalmitis.  Klin Monatsbl Augenheilkd. 1997;  210 274-288
  Google Scholar
• 39 Behrens-Baumann W, Paul H H, Ansorg R. Der Einfluss von Cortison bei der Behandlung der Pseudomonas-aeruginosa-Keratitis.  Klin Monatsbl Augenheilkd. 1981;  178 200-202
  Google Scholar
• 40 Behrens-Baumann W, Küster M. Der Einfluss von Kortikosteroiden bei der antimykotischen Therapie der Candida-Keratitis.  Klin Monatsbl Augenheilkd. 1987;  191 222-225
  Google Scholar
• 41 Schreiber W, Olbrisch A, Vorwerk C K et al. Combined topical fluconazole and corticosteroid treatment for experimental candida albicans keratomycosis.  Invest Ophthalmol Vis Sci. 2003;  44  2634-2643
  Google Scholar
• 42 Behrens-Baumann W, Pleyer U. Therapie und Prognose der bakteriellen Keratitis.  Ophthalmologe. 2007;  104 15-20
  Google Scholar
• 43 Behrens-Baumann W. Zur aktuellen Therapie der postoperativen Endophthalmitis.  Klin Monatsbl Augenheilkd. 2008;  225 919-923
  Google Scholar
• 44 Behrens-Baumann W. Diagnostik und Therapie der Keratomykose.  Ophthalmologe. 2009;  106 471-481
  Google Scholar
• 45 Gunduz K, Ozdemir O. Topical cyclosporin as an adjunct to topical acyclovir treatment in herpetic stromal keratitis.  Ophthalmic Res. 1997;  29 405-408
  Google Scholar
• 46 Heiligenhaus A, Steuhl K P. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: a pilot study.  Graefe’s Arch Clin Exp Ophthalmol. 1999;  237 435-438
  Google Scholar
• 47 Rao S N. Treatment of herpes simplex Virus stromal keratitis unresponsive to topical prednisolone 1 % with topical cyclosporine 0.05 %.  Am J Ophthalmol. 2006;  141 771-772
  Google Scholar
• 48 Heiligenhaus A, Bauer D, Meller D et al. Improvement of HSV-1 necrotizing keratitis with amniotic membrane transplantation.  Invest Ophthalmol Vis Sci. 2001;  42 1969-1974
  Google Scholar
• 49 Heiligenhaus A, Li H, Hernandez G alindo E E et al. Management of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation.  Br J Ophthalmol. 2003;  87 1215-1219
  Google Scholar
• 50 Shi W, Chen M, Xie L. Amniotic membrane transplantation combined with antiviral and steroid therapy for herpes necrotizing stromal keratitis.  Ophthalmology. 2007;  114 1476-1481
  Google Scholar
• 51 Saravia M, Zapata G, Ferraiolo P et al. Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis.  Graefe’s Arch Clin Exp Ophthalmol. 2009;  247 1409-1416
  Google Scholar
• 52 Barney N P, Foster C S. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.  Cornea. 1994;  13 232-236
  Google Scholar
• 53 Simon A L, Pavan-Langston D. Long-term oral aciclovir therapy. Effect on recurrent infectious herpes simplex keratitis in patients with and without grafts.  Ophthalmology. 1996;  103 1399-1405
  Google Scholar
• 54 Rooij van J, Rijneveld W J, Remeijer L J et al. A retrospective study on the effectiveness of oral acyclovir to prevent herpes simplex recurrence in corneal grafts.  Eur J Ophthalmol. 1995;  4  214-218
  Google Scholar
• 55 Rooij van J, Rijneveld W J, Remeijer L et al. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis. A placebo-controlled multicenter trial.  Ophthalmology. 2003;  110 1916-1919
  Google Scholar
• 56 Herpetic Eye Disease Study Group (HEDS) . Acyclovir for the prevention of recurrent herpes simplex virus eye disease.  N Engl J Med. 1998;  339 300-306
  Google Scholar
• 57 Uchoa U BC, Rezende R A, Carrasco M A et al. Long-term acyclovir use to prevent recurrent ocular herpes simplex virus infection.  Arch Ophthalmol. 2003;  121 1702-1704
  Google Scholar
• 58 Miserocchi E, Modorati G, Galli L et al. Efficacy of Valacyclovir vs Acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study.  Am J Ophthalmol. 2007;  144 547-551
  Google Scholar
• 59 Schwartz G S, Holland E J. Oral acyclovir for the management of herpes simplex virus keratitis in children.  Ophthalmology. 2000;  107 278-282
  Google Scholar
• 60 Duan R, Vries R D, Dun van J M et al. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.  J Infect Dis. 2009;  200  1402-1414
  Google Scholar
• 61 Kaye de S, Choudhary A. Herpes simplex keratitis.  Progr Ret Eye Res. 2006;  25 355-380
  Google Scholar
• 62 Tambasco F P, Cohen E J, Nguyen L H et al. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.  Arch Ophthalmol. 1999;  117 445-449
  Google Scholar
• 63 Foster C S, Duncan J. Penetrating keratoplasty for herpes simplex keratitis.  Am J Ophthalmol. 1981;  92 336-343
  Google Scholar
• 64 Moyes A L, Sugar A, Musch D C et al. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.  Arch Ophthalmol. 1994;  112 601-607
  Google Scholar
• 65 Kaufman H E. Epithelial erosion syndrome: metaherpetic keratitis.  Am J Ophthalmol. 1964;  57 983-987
  Google Scholar
• 66 Kaufman H E. Treatment of oral diseases of the cornea and external eye.  Progr Ret Eye Res. 2000;  19 69-85
  Google Scholar

Prof. Dr. Wolfgang Behrens-Baumann

Universitäts-Augenklinik, Otto-von-Guericke-Universität Magdeburg

Leipziger Str. 44

39120 Magdeburg

Phone: ++ 49/3 91/6 71 35 71

Fax: ++ 49/3 91/6 71 35 70

Email: augenklinik@ovgu.de